These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reinstitution of allopurinol therapy for gouty arthritis after cutaneous reactions. Fam AG; Paton TW; Chaiton A Can Med Assoc J; 1980 Jul; 123(2):128-9. PubMed ID: 6455189 [No Abstract] [Full Text] [Related]
4. A review of inpatients with adverse drug reactions to allopurinol. Khoo BP; Leow YH Singapore Med J; 2000 Apr; 41(4):156-60. PubMed ID: 11063179 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of desensitization to allopurinol following cutaneous reactions. Fam AG; Dunne SM; Iazzetta J; Paton TW Arthritis Rheum; 2001 Jan; 44(1):231-8. PubMed ID: 11212165 [TBL] [Abstract][Full Text] [Related]
6. Recent onset of rash, dehydration, and nonbloody diarrhea in an elderly man. Tyrell T; Gick J J Fam Pract; 2013 Sep; 62(9):E1-5. PubMed ID: 24080564 [TBL] [Abstract][Full Text] [Related]
7. Gouty patient hypersensitive to allopurinol: an intractable case. Wang D; Xhu XJ J Dermatol; 2005 Jan; 32(1):64-5. PubMed ID: 15841666 [No Abstract] [Full Text] [Related]
8. Allopurinol induced transitory giant fixed drug eruption: an atypical expression. Sehgal VN; Jain S J Dermatol; 1999 Mar; 26(3):198-9. PubMed ID: 10209930 [No Abstract] [Full Text] [Related]
9. Excess of ampicillin rashes associated with allopurinol or hyperuricemia. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med; 1972 Mar; 286(10):505-7. PubMed ID: 4258181 [No Abstract] [Full Text] [Related]
10. Drug eruptions induced by allopurinol associated with HLA-B*5801. Zeng M; Zhang M; Liu F; Yan W; Kong Q; Sang H Indian J Dermatol Venereol Leprol; 2015; 81(1):43-5. PubMed ID: 25566896 [TBL] [Abstract][Full Text] [Related]
11. Desensitization to allopurinol in patients with gout and cutaneous reactions. Fam AG; Lewtas J; Stein J; Paton TW Am J Med; 1992 Sep; 93(3):299-302. PubMed ID: 1388001 [TBL] [Abstract][Full Text] [Related]
12. [Allopurinol in the treatment of gout: initial results]. Serre H; Simon L; Claustre J Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):334-44. PubMed ID: 5701049 [No Abstract] [Full Text] [Related]
14. Fever, rash, and angioedema after a course of allopurinol. Yale SH; Yale ES; Mann DS Hosp Pract (1995); 1996 Mar; 31(3):92-4. PubMed ID: 8596012 [No Abstract] [Full Text] [Related]
15. Allopurinol in treatment of patients with gout and chronic renal failure. Bowie EA; Simmonds HA; North JD N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549 [No Abstract] [Full Text] [Related]
16. [Severe drug accidents and allopurinol]. Foucault V; Pibouin M; Lehry D; Beneton C; Bousser AM; Menez A; Chevrant-Breton J Ann Dermatol Venereol; 1988; 115(11):1169-72. PubMed ID: 2977076 [No Abstract] [Full Text] [Related]
17. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity? Dainichi T; Uchi H; Moroi Y; Furue M Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850 [No Abstract] [Full Text] [Related]
18. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol. Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112 [TBL] [Abstract][Full Text] [Related]
19. Allopurinol-induced palisaded neutrophilic and granulomatous dermatitis. Gordon K; Miteva M; Torchia D; Romanelli P Cutan Ocul Toxicol; 2012 Dec; 31(4):338-40. PubMed ID: 22250812 [TBL] [Abstract][Full Text] [Related]